Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $666.13 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $184.46 | 2 | $0 (2023) |
| UCB, Inc. | $131.53 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $108.75 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $37.07 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $31.52 | 2 | $0 (2021) |
| Beckman Coulter, Inc. | $26.20 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.01 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $19.62 | 1 | $0 (2024) |
| Insmed, Inc. | $19.61 | 1 | $0 (2024) |
| ABIOMED | $17.93 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $225.64 | 12 | Merck Sharp & Dohme LLC ($37.07) |
| 2023 | $69.06 | 1 | Janssen Pharmaceuticals, Inc ($69.06) |
| 2022 | $246.93 | 2 | UCB, Inc. ($131.53) |
| 2021 | $110.21 | 2 | AstraZeneca Pharmaceuticals LP ($92.98) |
| 2020 | $14.29 | 1 | E.R. Squibb & Sons, L.L.C. ($14.29) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: ANTIBIOTIC | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | Beckman Coulter, Inc. | UNICEL DXI ACCESS (Device) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Devices | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $69.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $115.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $131.53 | General |
| Category: Neurology | ||||||
| 07/28/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $92.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Cardiovascular | ||||||
| 10/22/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $3,432 | $1,011 |
| 2022 | 1 | 14 | 14 | $19,375 | $1,902 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 11 | 11 | $3,432 | $1,011 | 29.5% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 14 | 14 | $19,375 | $1,902 | 9.8% |
About Dr. Austin Zearley, DO
Dr. Austin Zearley, DO is a Emergency Medicine healthcare provider based in Norman, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2020. The National Provider Identifier (NPI) number assigned to this provider is 1760091417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Austin Zearley, DO has received a total of $666.13 in payments from pharmaceutical and medical device companies, with $225.64 received in 2024. These payments were reported across 18 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($666.13).
As a Medicare-enrolled provider, Zearley has provided services to 25 Medicare beneficiaries, totaling 25 services with total Medicare billing of $2,913. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Norman, OK
- Active Since 07/29/2020
- Last Updated 07/29/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1760091417
Products in Payments
- XARELTO (Drug) $184.46
- Briviact (Drug) $131.53
- LOKELMA (Drug) $92.98
- ZERBAXA (Drug) $37.07
- ELIQUIS (Drug) $31.52
- UNICEL DXI ACCESS (Device) $26.20
- OFEV (Drug) $24.01
- DUPIXENT (Biological) $19.62
- Arikayce (Drug) $19.61
- Impella (Device) $17.93
- NUCALA (Biological) $17.86
- NUZYRA (Drug) $17.34
- TEZSPIRE (Biological) $15.77
- GIAPREZA (Drug) $15.28
- GLASSIA (Biological) $14.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Norman
Sergio Garcia, M.d, M.D
Emergency Medicine — Payments: $17,079
Angela Carrick, D.o, D.O
Emergency Medicine — Payments: $3,194
Christopher Smith, Do, DO
Emergency Medicine — Payments: $1,989
Dr. Jerad Ball, D.o, D.O
Emergency Medicine — Payments: $970.66
Dr. Spencer Baird, Do, DO
Emergency Medicine — Payments: $867.41
Dr. Allen Baughman, D.o, D.O
Emergency Medicine — Payments: $836.58